Give a gift to Leukaemia Care and help us support leukaemia patients
We use cookies to provide a better service. Keep browsing if you're happy with this, or read our cookie policy.
Menu
08088 010 444
Search results for "benefits"
Page
We talk you through state benefits, eligibility and more. It's important to note that the purpose of this webpage is to give an overview of the benefits that may be relevant to you as a leukaemia patient. Speak to our Advocacy team for guidance on personal claims.
Blog
Leukaemia Care trustee Kate Stallard is in remission from acute promyelocytic leukaemia (APL), and since her diagnosis she has found gardening to be a way to cope. Here, she talks about how gardening helped her, and how it might help you too.
When you are diagnosed with cancer, you automatically meet the disability definition under the Equality Act (2010). In this blog, we've taken information from our 'The Next Stage' booklet on what benefits you are entitled to.
After a blood cancer diagnosis, keeping fit and active might be the last thing on your mind, but exercise can benefit both your treatment and recovery. Here, our Nurse Advisor, Fiona Heath, explains more.
A cancer diagnosis can affect many aspects of your life including your finances, working arrangements and travel. This section will help provide information and advice on the practical issues you may need to consider after diagnosis and during treatment.
There is a huge amount of research and information available on the benefits of exercising with cancer.
Stories
59-year-old Janine was diagnosed with acute myeloid leukaemia (AML) in November 2019 and suffered a relapse two years later. Full of anxiety and questions, she approached Leukaemia Care for one-to-one buddy support. She was matched with 69-year-old Judith who’d been diagnosed with the same type of leukaemia seven years earlier. Their mutual support has since blossomed into friendship. Janine and Judith share their BBC Lifeline story here…
It’s been around two weeks since the Chancellor of the Exchequer announced his Autumn Statement, setting out the spending priorities of the Government. In this blog, our Policy and Evidence Manager, Charlotte Crowley, reflects on the announcements and their impact on you.
News
Leukaemia Care campaigns for the Scottish Medicines Consortium (SMC) to approve oral azacitidine on the NHS in Scotland for adults with acute myeloid leukaemia (AML).
The SMC has decided not to approve Besremi, also known as ropeginterferon alfa-2b, for use on the NHS in Scotland. This treatment is a monotherapy, intended to treat adult patients with polycythaemia vera (PV), without symptoms of an enlarged spleen.
chat